A Case of Cogential Fiber Type Disproportion With Multiple Anomalies by 源��꽭�썕 et al.
대 한 소 아 신 경 학 회 지
□증 례□ Vol. 14, No. 2, November, 2006
1)
Introduction
Congenital fiber type disproportion (CFTD)
is a rare form of congenital myopathy charac-
terized by the smallness and marked predo-
minance of type 1 fibers and which presents as
congenital hypotonia, delayed motor milestones,
joint contracture, and skeletal deformities.
Muscle biopsy reveals the type 1 fibers are
more than 12% smaller than the type 2 fibers
in seize1-3). The term has been used to describe
the histological pattern, resulting in confusion
about the clinical features of CFTD4, 5). To
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date, our understanding of CFTD has been
hampered by the lack of large case series and
general consensus on diagnostic criteria. Here
we describe a 24-month-old boy who pre-
sented with muscle hypotonia, delayed motor
milestones, mental retardation with generalized
tonic clonic seizure, and pathologic findings of
CFTD. Additional findings included left cryp-
torchidism, congenital subluxation of hip, con-
tracture of ankle joint, diffuse brain atrophy,
and optic nerve atrophy.
Case Report
A 2-year-old boy presented with progres-
sive muscle weakness, hypotonia, generalized
tonic clonic seizure and delayed psychomotor
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Congenital fiber type disproportion (CFTD)은 근긴장도 저하, 발달 지연, 관절 구축, 골
격계 이상 등의 임상 증상을 나타내는 선천성 근육질환으로 근육 조직 소견에서 1형 근섬유
의 크기 감소와 수적 증가를 특징으로 하는데 1형 근섬유가 2형 근섬유보다 지름이 12% 이
상 작아야 한다. 저자들은 근긴장도 저하, 발달 지연, 정신 지체, 전신성 강직 간대 발작, 잠
복고환, 고관절 불완전탈구, 발목관절 구축, 미만성 뇌위축, 시신경 위축 등의 소견을 보이면
서 근육조직 검사에서 확진된 CFTD 1례를 경험하였기에 이를 보고하고자 한다.
Key Words : Congenital fiber type disproprtion (CFTD), Congenital myopathy, Mental
retardation, Seizure
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milestones. He was born at 37 weeks with
birth weight of 2,460 g due to his mothers
pregnancy induced hypertension. The Apgar
score was 9 at 1 min and he had no perinatal
problem. At the age of 12 months, he was
hospitalized due to feeding difficulties and ab-
normal movements such like head dropping and
arm extension associated with regurgitation of
meals at supine position since 5 months of age.
Neither clinical nor electrographic seizure acti-
vities are noted on 24 hour video monitoring
during the hospital stay. His abnormal move-
ment disappeared after introducing H2 ant-
agonist and metoclopramide. His head circum-
ference and weight were below the 5th per-
centile. Height was around the 25th percentile.
He showed no dysmorphic feature such as long
face or high arched palate. His deep tendon re-
flexes were decreased and he had no Babinski
response. Mental milestones were abnormal. He
obtained head control at 3 months, creeping at
7 months, sitting with arm support at 10
months, but could not crawl and no sit by
himself yet. His verbal speech was limited by
two to three words and his eyes could not
follow objects. Deterioration of motor and men-
tal function was more rapidly progressed after
onset of seizure at 13 months. He also showed
left cryptorchidism, congenital subluxation of
hip, contracture of ankle joint and optic nerve
atrophy.
He had a normal male karyotype. Serum CK
level, metabolic tests including serum/CSF
lactate and pyruvate, urine organic acid and
serum aminoacids/long chain fatty acid results
were not specific. At the age of 13 months,
asymmetric slowing on left side of brain and
frequent sharp wave discharges from right
frontal area were noted on EEG. Brain MRI
revealed only diffuse atrophy of brain with
passive dilatation of ventricles at 18 months of
age (Fig. 1). Since he had profound psycho-
motor retardation, unexplained diffuse brain
atrophy on MRI, and abnormal EEG, we per-
formed muscle biopsy to find the cause of his
illness.
Muscle tissue was obtained from left rectus
femoris muscle at 2 years of age. Sections of the
muscle (8 µm thick) were stained with hema-
toxylin-eosin (H-E), modified Gomori trichrome
technique, succinate dehydronase, adenosine tri-
phosphatase (ATPase, at pH 9.4, 4.6, and 4.3),
and nicotinamide adenine dinucleotide (NADH)-
tetrazolium reductase (TR) statin. There showed
selective type 1 fiber atrophy with type 1 fiber
predominance of more than 90% of the myofibers
(Fig. 2). The mean diameter of type 1 fibers are
more than 12% smaller than type 2 fiber. There
were no special findings such as central cores,
Fig. 1. Axial T2-weighted brain MRI at 18
months of age. Brain MRI showed diffuse atrophy
of brain with passive dilatation of ventricles.
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minicores, central nuclei, nemaline bodies,
reducing bodies, target fibers, ragged red fibers,
and specific metabolic accumulation.
Discussion
CFTD is a congenital myopathy first de-
lineated by Brooke in 19731). The criterion of
relative type 1 hypotrophy rather than the mean
type 2A or type 2B fiber diameter became the
central diagnostic feature of the CFTD. Patients
with CFTD shared congenital hypotonia,
generalized weakness, failure to thrive, multiple
joint contractures, scoliosis, long thin face, and
high arched palate. Brooke suggested that
CFTD was likely to have a genetic basis. Cases
with autosomal dominant or recessive inheri-
tance have been reported6). However, nobody in
the family had symptoms of myopathy in our
case.
Since many neuromuscular disorders share
fiber size disproportion (FSD) of 12% or great-
er, they should be considered as differential
diagnoses to exclude before making diagnosis
of CFTD. It has been shown that while FSD
is a feature observed in approximately 7% of
pediatric muscle biopsies, only 10 to 20% of
those children actually have CFTD7). In addi-
tion, CFTD could accompany many central
nervous system dysfunction such as perinatal
asphyxia, idiopathic mental retardation, cerebral
malformations, or Leigh disease. Many myopa-
thic processes have FSD as an ancillary fea-
ture, too. They cannot be distinguished from
CFTD by clinical features alone. Diagnosis of
these disorders needs their own histological
findings. Other authors have used the term
secondary fiber size disproportion when FSD
occurs in this context8).
In our case, he was manifested as a floppy
infant and demonstrated unexplained progres-
sing hypotonia, and proximal muscle weakness
with pathological criteria of FSD>12% and
type I fiber predominance >90% in muscle
biopsy in the absence of other specific histolo-
gical abnormalities. These features met the
criteria for CFTD by Brooke1). His clinical fea-
tures including congenital subluxation of the
hip, ankle joint contracture, and foot defor-
mities are the same as other previous cases of
CFTD8). Contractures are usually evident at
birth, but in some patients with marked weak-
ness and severely impaired mobility, they can
develop in later period. The most commonly
affected joints are described to be the ankles8).
Cryptorchidism, short stature and poor weight
gain have frequently been reported as clinical
characteristics of CFTD9). These features are
similar to clinical characteristics of our case.
The mental milestones of our patient were
markedly retarded than those of any previously
reported case. To the best of our knowledge,
his generalized tonic clonic seizure is rarely
Fig. 2. Pathologic examination of left rectus
femoris muscle at 2 years of age. Muscle biopsy
shows selective type 1 fiber atrophy with type 1
fiber predominance of more than 90% of the
myofibers (NADH-TR stain, ×400)
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found in CFTD cases. In addition, his brain
MRI showed evident cerebral atrophy in the
absence of other causes like metabolic or peri-
natal asphyxia. Though the findings of the
case were also reported in congenital muscular
dystrophy in terms of structural changes of
the central nervous system10), the characteristic
histological features such as many degenera-
ting or regenerating fibers, or increased con-
nective tissue of congenital muscular dystrophy
were absent in the case8). Nevertheless, mental
function in CFTD is usually preserved and our
literature search also revealed only a few re-
ports of mental retardation in CFTD cases.
Clarke et al reported only two patients (3%)
with intellectual disability after reviewing 117
cases of CFTD8).
Shibita et al11) reported a boy with feeding
difficulties from early infancy, who required
artificial ventilation suffering mental retarda-
tion. His first muscle biopsy done at the age
of 1 month showed CFTD, but the histologic
findings significantly improved on the second
biopsy at 1 year of age showing type 1 fiber
predominance and characteristic morphologic
findings such as the formation of nemalines
and cores. Quazi et al12) also reported three
unrelated boys with marked, central, nonpro-
gressive hypotonia, severe psychomotor retar-
dation, seizures, delayed and disharmonic
skeletal maturation, and CFTD.
It still remains unclear whether the seizures
affected his mental milestones or not and what
the main cause was for his seizure. He may
be a case of CFTD with type I predominance
associated with seizure, mental retardation, dif-
fuse brain atrophy, left cryptorchidism, optic
nerve atrophy, congenital subluxation of hip,
and contracure of ankle joint.
Unlike other previous cases, he did not
make a significant improvement in both motor
and mental development. It needs to be clari-
fied why he did not. Many children with
CFTD reported later generally had good prog-
nosis. Apparently the disproportion of diameter
is not a permanent feature during the course
of CFTD. It has been established that a strik-
ing correlation between changes in the degree
of FSD over time and changes in disease se-
verity in some cases is likely to exist8). These
findings suggest that for an individual patient,
the clinical course may in part depend on
whether type 1 fiber hypotrophy resolves or
progresses over time.
In conclusion, the frequent association of
CFTD with other diseases suggests that CFTD
may not be a specific myopathy but a histo-
logical abnormality due to different pathogenic
insults which interfere with the normal growth
and maturation of the muscle fibers. CFTD is
a congenital myopathy whose diagnosis can be
made only by muscle biopsy, rather than a
distinct syndrome whose diagnosis can be as-
sumed on the basis of clinical characteristics
alone. We believe its pathological pattern could
be shared with other conditions. Moreover, we
should consider CFTD as the differential diag-
nosis of early onset myopathies.
Abstract
Congenital fiber type disproportion (CFTD)
is a rare form of congenital myopathy charac-
terized by the smallness and the marked pre-
dominance of type 1 fibers, which presents
congenital hypotonia, delayed motor milestones,
joint contractures, and skeletal deformities. The
muscle biopsy reveals the type 1 fibers are
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more than 12% smaller than the type 2 fibers
in size. We describe a 24-month-old boy who
presented muscle hypotonia, delayed motor
milestones, mental retardation with generalized
tonic clonic seizures, and the muscle pathologic
findings of CFTD. Additional findings included
left cryptorchidism, congenital subluxation of
the hip, contractures of ankle joints, diffuse
brain atrophy, and optic nerve atrophy. We
should consider CFTD as a differential diagno-
sis of early onset myopathy.
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